Literature DB >> 14658987

Gender-specific considerations in the treatment of mood disorders in women across the life cycle.

Lee S Cohen1.   

Abstract

Major depressive disorder in women is a significant health concern. Rates of depression in women are approximately twice those seen in men. Observations of gender-based differences in prevalence, presentation, and treatment response in depression raise questions about the underlying causes of such differences. In addition, the specific factors that predict vulnerability to reproductive-associated mood disturbance, including premenstrual dysphoric disorder, postpartum depression, and perimenopausal mood disturbance, remain to be delineated. While a growing amount of controlled data is emerging that describes response to treatment in women who suffer from these disorders, further investigation is needed to identify subgroups of women who are most at risk for depression and to define the most effective treatments for these patients.

Entities:  

Mesh:

Year:  2003        PMID: 14658987

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  5 in total

Review 1.  Sex differences in the pharmacokinetics of antidepressants: influence of female sex hormones and oral contraceptives.

Authors:  Valérie A Damoiseaux; Johannes H Proost; Vincent C R Jiawan; Barbro N Melgert
Journal:  Clin Pharmacokinet       Date:  2014-06       Impact factor: 6.447

2.  Interaction between TPH1 and GNB3 genotypes and electroconvulsive therapy in major depression.

Authors:  S Anttila; K Huuhka; M Huuhka; R Rontu; K M Mattila; E Leinonen; T Lehtimäki
Journal:  J Neural Transm (Vienna)       Date:  2006-10-27       Impact factor: 3.575

3.  White matter hyperintensities and the course of depressive symptoms in elderly people with mild dementia.

Authors:  Hogne Soennesyn; Ketil Oppedal; Ole Jacob Greve; Friederike Fritze; Bjørn H Auestad; Sabine P Nore; Mona K Beyer; Dag Aarsland
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2012-03-31

4.  Differential clinical effects of fluvoxamine by the effect of age in Japanese female major depressive patients.

Authors:  Hisashi Higuchi; Kazuhiro Sato; Shingo Naito; Keizo Yoshida; Hitoshi Takahashi; Mitsuhiro Kamata; Noboru Yamaguchi
Journal:  Neuropsychiatr Dis Treat       Date:  2009-04-08       Impact factor: 2.570

5.  Is schizoaffective disorder a distinct categorical diagnosis? A critical review of the literature.

Authors:  Daniel J Abrams; Donald C Rojas; David B Arciniegas
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.